Syneos Health is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. They translate unique clinical, medical affairs, and commercial insights into outcomes to address modern market realities. They bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together they share insights, use the latest technologies, and apply advanced business practices to speed their customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable, and inclusive culture that cares for colleagues, customers, patients, communities, and the environment. This United States based company was founded in 1985. Their last investment was a $524.65M Post-IPO Secondary investment at 01 March 2021.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Secondary | $524.65M | - | 01 Mar 2021 | |
| Private Equity Round | Unknown | 2 |
|
01 Aug 2016 |
| Venture Round | Unknown | 1 |
|
01 Jan 1999 |
No recent news or press coverage available for Syneos Health.
We care about your data, and we'd love to use cookies make your experience better.
